Ae‐Young Her

ORCID: 0000-0002-9990-6843
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiovascular Function and Risk Factors
  • Cerebrovascular and Carotid Artery Diseases
  • Peripheral Artery Disease Management
  • Cardiac Valve Diseases and Treatments
  • Lipoproteins and Cardiovascular Health
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Disease and Adiposity
  • Advanced MRI Techniques and Applications
  • Aortic aneurysm repair treatments
  • Cardiac Health and Mental Health
  • Advanced X-ray and CT Imaging
  • Blood Pressure and Hypertension Studies
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Heart Failure Treatment and Management
  • Diabetes Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac and Coronary Surgery Techniques
  • Diabetic Foot Ulcer Assessment and Management
  • Cardiovascular Health and Disease Prevention
  • Vascular Procedures and Complications

Kangwon National University
2016-2025

National University College
2024

New Generation University College
2024

SHARE
2024

Science Health Allied Research Education
2024

Singapore-HUJ Alliance for Research and Enterprise
2024

Kangwon National University Hospital
2012-2023

Yonsei University
2008-2023

Versus Arthritis
2021

Weill Cornell Medicine
2019

Use of intravascular ultrasound (IVUS) promotes better clinical outcomes for coronary intervention in complex lesions. However, randomized data demonstrating the usefulness IVUS are limited lesions treated with drug-eluting stents.To determine whether long-term IVUS-guided stent implantation superior to those angiography-guided patients long lesions.The Impact Intravascular Ultrasound Guidance on Outcomes Xience Prime Stents Long Lesions (IVUS-XPL) randomized, multicenter trial was conducted...

10.1001/jama.2015.15454 article EN JAMA 2015-11-10

<h3>Importance</h3> Discontinuing aspirin after short-term dual antiplatelet therapy (DAPT) was evaluated as a bleeding reduction strategy. However, the strategy of ticagrelor monotherapy has not been exclusively in patients with acute coronary syndromes (ACS). <h3>Objective</h3> To determine whether switching to 3 months DAPT reduces net adverse clinical events compared ticagrelor-based 12-month ACS treated drug-eluting stents. <h3>Design, Setting, and Participants</h3> A randomized...

10.1001/jama.2020.7580 article EN JAMA 2020-06-16

Clinical reads of coronary computed tomography angiography (CTA), especially by less experienced readers, may result in overestimation artery disease stenosis severity compared with expert interpretation. Artificial intelligence (AI)-based solutions applied to CTA overcome these limitations.This study the performance for detection and grading stenoses using artificial intelligence-enabled quantitative (AI-QCT) analyses core lab-interpreted CTA, lab (QCA), invasive fractional flow reserve...

10.1016/j.jcmg.2021.10.020 article EN cc-by JACC. Cardiovascular imaging 2022-02-16

Left atrial (LA) fibrosis is a main determinant of LA remodeling and development fibrillation. However, non-invasive prediction challenging. We investigated whether preoperative strain as measured by speckle tracking echocardiography could predict the degree reverse after mitral valve (MV) surgery.Speckle volume measurements were performed in 50 patients one day before MV surgery. tissues obtained during surgery, degrees their interstitial fibroses measured. repeated within 30 days surgery...

10.4070/kcj.2012.42.5.311 article EN Korean Circulation Journal 2012-01-01

Noninvasive stress testing is commonly used for detection of coronary ischemia but possesses variable accuracy and may result in excessive health care costs. This study aimed to derive validate an artificial intelligence-guided quantitative computed tomography angiography (AI-QCT) model the diagnosis that integrates atherosclerosis vascular morphology measures (AI-QCTISCHEMIA) evaluate its prognostic utility major adverse cardiovascular events (MACE). A post hoc analysis CREDENCE (Computed...

10.1016/j.jcmg.2024.01.007 article EN cc-by JACC. Cardiovascular imaging 2024-03-13

The Genoss paclitaxel-coated balloon (PCB) is a novel PCB with shellac and vitamin E as excipients, enhancing drug delivery to the target lesion minimizing restenosis. This study aimed compare quantitative coronary angiographic outcomes at 6 months after treatment of de novo artery disease (CAD) 2 different types PCBs. prospective, multicenter, noninferiority trial randomized 204 patients chronic syndrome or stabilized acute E-based reference (SeQuent Please NEO) in 1:1 ratio. primary...

10.1016/j.jacasi.2024.10.028 article EN cc-by-nc-nd JACC Asia 2025-01-01

The aim of this study was to investigate the combined usefulness platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte (NLR) in predicting long-term adverse events patients who have undergone percutaneous coronary intervention (PCI) with a drug-eluting stent (DES).798 stable angina, unstable angina non-ST elevated myocardial infarction (NSTEMI) underwent elective successful PCI DES were consecutively enrolled. value PLR NLR artery disease (CAD) correlations between these markers...

10.1371/journal.pone.0133934 article EN cc-by PLoS ONE 2015-07-24

Coronary artery disease (CAD) is currently the leading cause of death globally, and prevalence this growing more rapidly in Asia-Pacific region than Western countries. Although use metal coronary stents has increased thanks to advancement safety efficacy newer generation drug eluting stent (DES), patients are still negatively affected by some inherent limitations type treatment, such as thrombosis or restenosis, including neoatherosclerosis, obligatory dual antiplatelet therapy (DAPT) with...

10.5603/cj.a2019.0093 article EN cc-by-nc-nd Cardiology Journal 2019-09-30

Stress imaging has been the standard for diagnosing functionally significant coronary artery disease. It is unknown whether novel, atherosclerotic plaque measures improve accuracy beyond stenosis invasive fractional flow reserve (FFR) measurement.To compare diagnostic of comprehensive anatomic (obstructive and nonobstructive plaque) vs functional estimating vessel-specific FFR.Controlled clinical trial with a multicenter derivation-validation cohort patients referred nonemergent angiography....

10.1001/jamacardio.2020.3409 article EN JAMA Cardiology 2020-08-19

We compared diagnostic performance, costs, and association with major adverse cardiovascular events (MACE) of clinical coronary computed tomography angiography (CCTA) interpretation versus semiautomated approach that use artificial intelligence machine learning for atherosclerosis imaging-quantitative (AI-QCT) patients being referred nonemergent invasive (ICA).CCTA data from individuals enrolled into the randomized controlled Computed Tomographic Angiography Selective Cardiac Catheterization...

10.1002/clc.23995 article EN cc-by Clinical Cardiology 2023-02-27

Data on drug-coated balloon (DCB) treatment in the context of diabetes mellitus (DM) and multivessel coronary artery disease (CAD) are limited. We aimed to investigate clinical impact DCB-based revascularization percutaneous intervention (PCI) patients with DM CAD.A total 254 (104 DM) successfully treated DCB alone or combined drug-eluting stent (DES) were retrospectively enrolled (DCB-based group) compared propensity-matched second-generation DES from PTRG-DES registry (n = 13,160 patients)...

10.1186/s12933-023-01853-0 article EN cc-by Cardiovascular Diabetology 2023-05-20

ABSTRACT Background There is a paucity of data regarding drug‐coated balloon (DCB) treatment in the context left main (LM) true bifurcation lesions. Aims The aim this study was to evaluate safety and efficacy DCB‐based for unprotected LM Methods A total 39 patients with lesion (Medina: 1,1,1/0,1,1/1,0,1) who were successfully treated DCB alone or combination drug‐eluting stent (DES) retrospectively enrolled into group. They compared propensity‐matched second‐generation DES from COBIS III...

10.1002/ccd.31416 article EN Catheterization and Cardiovascular Interventions 2025-01-22

Drug-coated balloon (DCB) treatment is an emerging strategy for de novo coronary artery disease (CAD), but procedural optimization remains uncertain. This study analyzed 317 patients who underwent DCB-based intervention CAD and angiographic follow-up: SR (successful, stent-like result: diameter stenosis < 20% at follow-up angiography, n = 84, 93 lesions) Non-SR (n 224, 358 groups. Baseline clinical lesion characteristics were similar, except that lesions had larger diameter. In lesions,...

10.1038/s41598-025-92052-2 article EN cc-by-nc-nd Scientific Reports 2025-03-18

Data on drug-coated balloon (DCB) treatment in elderly patients are limited. This study was to evaluate the efficacy of DCB percutaneous coronary intervention (PCI) among patients. A retrospective analysis included 232 aged 75 years or older with artery disease who underwent successful PCI using either alone combination drug-eluting stent (DES) based pre-dilation results (DCB-based PCI). These were compared 1818 second-generation DES implantation (DES-only The endpoint major adverse...

10.26599/1671-5411.2025.01.001 article EN PubMed 2025-01-28
Coming Soon ...